STOCK TITAN

Akouos to Present at Bank of America 2022 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Akouos, Inc. (NASDAQ: AKUS) announced that its CEO, Manny Simons, will present at the Bank of America 2022 Healthcare Conference on May 10, 2022, at 10:00 a.m. PDT in Las Vegas, Nevada. The presentation will focus on the company’s dedication to developing gene therapies for disabling hearing loss worldwide. A live webcast will be available through www.akouos.com approximately 15 minutes prior to start time, with an archived replay accessible for 30 days.

Positive
  • None.
Negative
  • None.

BOSTON, May 04, 2022 (GLOBE NEWSWIRE) -- Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced that Manny Simons, Ph.D., M.B.A., co-founder, president, and chief executive officer of Akouos, will participate in a presentation at the Bank of America 2022 Healthcare Conference on Tuesday, May 10 at 10:00 a.m. PDT in Las Vegas, Nevada.

A live webcast of the presentation will be accessible through the investors section of www.akouos.com. To access the webcast, please go to the Akouos website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. An archived replay will be available on Akouos’s website for 30 days following the conference.

About Akouos

Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals living with disabling hearing loss worldwide. Leveraging its precision genetic medicine platform that incorporates a proprietary adeno-associated viral (AAV) vector library and a novel delivery approach, Akouos is focused on developing precision therapies for forms of sensorineural hearing loss. Headquartered in Boston, Akouos was founded in 2016 by leaders in the fields of neurotology, genetics, inner ear drug delivery, and AAV gene therapy.

Contacts

Media:
Katie Engleman, 1AB
katie@1abmedia.com

Investors:
Courtney Turiano, Stern Investor Relations
Courtney.Turiano@sternir.com


FAQ

When will Akouos present at the Bank of America 2022 Healthcare Conference?

Akouos will present on May 10, 2022, at 10:00 a.m. PDT.

Who is presenting for Akouos at the conference?

Manny Simons, Ph.D., M.B.A., the co-founder and CEO of Akouos, will present.

How can I access the Akouos presentation online?

The presentation can be accessed via a live webcast at www.akouos.com.

Is there a replay available for the Akouos conference presentation?

Yes, an archived replay will be available on Akouos's website for 30 days after the conference.

What is the focus of Akouos as a company?

Akouos focuses on developing gene therapies for restoring and improving hearing in individuals with disabling hearing loss.

AKUS

NASDAQ:AKUS

AKUS Rankings

AKUS Latest News

AKUS Stock Data

491.02M
36.53M
1.13%
104.91%
2.35%
Biotechnology
Healthcare
Link
United States
Boston